CADX Related Analyst Ratings
-
Oppenheimer Downgrades Cadence Pharmaceuticals (CADX) to Perform
-
JMP Securities Downgrades Cadence Pharmaceuticals (CADX) to Underperform
-
Ladenburg Thalmann Downgrades Cadence Pharma (CADX) to Neutral
-
Wedbush Morgan Initiates Coverage on Cadence Pharmaceuticals (CADX) with a Buy; Weakness Provides Attractive Entry Point
-
Ladenburg Thalmann Starts Cadence Pharma (CADX) at Buy
-
Oppenheimer Initiates Coverage on Cadence Pharmaceuticals (CADX) with an Outperform
-
Cowen & Co Initiates Coverage on Cadence Pharma (CADX) with an Outperform
-
Susquehanna Starts Cadence Pharmaceuticals (CADX) at Positive
-
American Technology Research Starts Cadence Pharma (CADX) at Buy
-
Merrill Lynch and Deutsche Bank Start Cadence Pharmaceuticals (CADX) at Buy
Back to CADX Stock Lookup
